To build user trust in high-stakes AI, transparency is a core product feature, not an option. This means surfacing the AI's reasoning, showing its confidence levels, and making trade-offs visible. This clarity transforms the AI from a black box into a collaborative tool, bringing the user into the decision loop.

To overcome resistance, AI in healthcare must be positioned as a tool that enhances, not replaces, the physician. The system provides a data-driven playbook of treatment options, but the final, nuanced decision rightfully remains with the doctor, fostering trust and adoption.

For an AI optimizing physical infrastructure like buildings, customer adoption hinges on explainability. Product leader John Boothroyd's team had to create visual representations showing how the AI made decisions to gain trust. This proves transparency is essential for automated systems with real-world consequences.

By analyzing a model predicting Alzheimer's, Goodfire discovered it relied on the length of cell-free DNA fragments—a previously overlooked signal. This demonstrates how interpretability can extract new, testable scientific hypotheses from high-performing "black box" models.

A key risk for AI in healthcare is its tendency to present information with unwarranted certainty, like an "overconfident intern who doesn't know what they don't know." To be safe, these systems must display "calibrated uncertainty," show their sources, and have clear accountability frameworks for when they are inevitably wrong.

In partnership with institutions like Mayo Clinic, Goodfire applied interpretability tools to specialized foundation models. This process successfully identified new, previously unknown biomarkers for Alzheimer's, showcasing how understanding a model's internals can lead to tangible scientific breakthroughs.

For AI systems to be adopted in scientific labs, they must be interpretable. Researchers need to understand the 'why' behind an AI's experimental plan to validate and trust the process, making interpretability a more critical feature than raw predictive power.

The AI platform discovers patterns in patient movement that expert clinicians felt were significant but couldn't objectively measure. This process of data-driven confirmation helps build trust and accelerates the adoption of AI tools by providing evidence for long-held clinical instincts, turning a subjective feeling into objective proof.

Achieving explainability in AI for drug development isn't about post-hoc analysis. It requires building models from the ground up using inherently interpretable data like RNA sequencing and mutational profiles. When the inputs are explainable, the model's outputs become explainable by design.